疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
  R: C! Z4 O( g" G
& m* a! h# U6 ohttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
/ H: m: `* z. v1 A short history of vaccination 1
$ Q/ }, G9 |3 I2 Vaccine immunology 14
$ R& M, O4 d/ W' }+ q. S3 The vaccine industry 33
; M( t) {7 o% n. L4 Vaccine manufacturing 44
7 ?5 L6 i$ J2 h5 f% V+ O5 Evolution of adjuvants across the centuries 58
/ d1 [( M9 K  v% w# G8 Z; Z( t6 Vaccine additives and manufacturing residuals in the United States:
9 ^. V6 g4 {9 G4 q4 L9 r% [9 N$ c2 Z  flicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
( j. R0 \  {$ o7 A: `9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
  ~- b& y; S' a) Z% \12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
4 A1 `  e5 d- E2 P5 f16 Human papillomavirus vaccines 235
* t0 b% {9 ^# S3 G7 K0 l0 Q17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
# l9 C3 a3 t9 c' q* s19 Japanese encephalitis vaccines 312
" u- X+ i1 u. G, C( Y20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
1 r0 e* y6 j; `0 K28 Poliovirus vaccine-live 598
3 k. ~! b& o' o! n  i, \) a29 Rabies vaccines .646
# v9 T9 M% J. d5 y+ Z" [30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
0 {. A0 X" K/ N8 n. V8 O" T33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
/ Q; h4 \: p, D: _" L; U& i+ [38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
; b6 e% f: K' G" _/ x* H3 C41 Biodefense and special pathogen vaccines 1008
) B; u. R$ R7 b  h42 Therapeutic cancer vaccines 1018
, `6 t* ]; ~& s- O8 i43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
* V: N2 Y' Z( f- [46 Ebola vaccine 1060
# \& W1 P9 A( X8 q8 t( b47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
5 B/ V! n, Q% ^- x1 p! F50 Herpes simplex virus vaccines 1090
& M4 N8 V. W6 a( k51 Human immunodeficiency virus vaccines 1097
) g* y2 Q" [+ }4 @% _5 c0 n52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
4 X2 X) M( Z/ _5 o3 H( l+ T% b54 Noninfectious disease vaccines 1138
$ p, m  g+ _- t& g55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
# X: _1 t& \" Q( R- Z' |! c" t56 Parasitic disease vaccines 1154
: v# ?, I8 J3 J# Z# v% f1 D57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
7 {5 i/ C0 Q' a59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
+ `8 @( L3 e" t# D. |6 ^' H61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
; O( r' F# v. `  q2 Z) e2 @SECTION 4: Vaccination of special groups
4 u+ b* K, O( \7 ]6 F63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
( ~9 t0 L/ l3 c0 w+ u67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
( D# l( T: O" r3 K  F  A74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
3 W5 G+ C7 I0 N: q, o. y! t76 Vaccine safety 1464
77 Legal issues . 1481
3 Z9 W8 N, U: y, Y! r% `9 r4 }78 Ethics 1508
* B$ B5 \' L2 h



4 Z9 i* q0 h# w  \0 Y. p

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

! l" J! X( A& s" u- ~& RVaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
3 [+ e8 x7 d/ X# v3 ^
+ E/ @' b7 c, Q, Uhttp://yun.baidu.com/share/link? ... 1&uk=3810996606

+ R! a8 f, M! J* _1 U6 H9 {SECTION 1: General aspects of vaccination
7 d* l( ^$ X: H' l; k; Y1 A short history of vaccination 1
3 ]+ w, g* T) B) K9 r2 Vaccine immunology 14
) ~% q  p8 y7 F; o3 The vaccine industry 33
4 Vaccine manufacturing 44
/ F$ z' x' r+ u$ Y  M- R5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
( Q7 A. }; ^; U* y6 c: t# G6 G! f7 Passive immunization 80
0 c2 u0 l; [2 O: B# U% C8 General immunization practices 88
4 J/ g) `! ~9 d6 U/ oSECTION 2: Licensed vaccines
4 _2 h5 h! r& I( b, K& @2 \9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
2 {, m* j# h/ v12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
0 n. G# b& ?& o# E* [) i15 Hepatitis B vaccines 205
& [$ f) m. K4 h9 l16 Human papillomavirus vaccines 235
- T( d) ]* S4 x9 F$ `- D17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
+ x) P9 `! O* q/ X  h+ A4 o21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
# s' Y: y/ |" U8 s25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
8 k' n' h* {* C+ P4 G$ d' d27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
6 l# m) o4 G- v+ g( V$ X/ t( y30 Rotavirus vaccines . 669
31 Rubella vaccine 688
, U4 L( F* O% f) G32 Smallpox and vaccinia 718
8 q- s- U# W6 w7 e9 C33 Tetanus toxoid 746
* ~! V$ h0 j1 b( n; X& o34 Tick-borne encephalitis virus vaccines 773
3 d; x3 L: l2 k& K35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
+ o3 v) D6 i$ e8 u4 ^3 }39 Zoster vaccine 969
40 Combination vaccines 981
' S* Q& U/ D$ ?SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
: g! C( Z6 ?" g42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
. j! u6 F0 f8 @5 m( z6 D; f9 U44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
# Q5 \: l# f0 @* Q$ y47 Epstein-Barr virus vaccines 1068
% v1 N1 u  d" u3 q48 Hepatitis C vaccines 1074
! ?5 @0 E/ S" D( K, E49 Hepatitis E vaccines 1085
9 `( {+ G$ ?/ O50 Herpes simplex virus vaccines 1090
  i5 Z$ g. Q/ Z1 S6 Q" v' _51 Human immunodeficiency virus vaccines 1097
! G1 a. g% _( U: z* S52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
2 J. V3 Y/ T- r55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
: [( {6 \- f/ |! ]+ W* B$ d56 Parasitic disease vaccines 1154
$ ]7 i) t2 a% Q57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
1 h! l0 [7 i' D! K59 Streptococcus group B vaccines 1176
3 E4 J. \! t& Q60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
0 @1 P2 _/ u1 E' `0 ^62 The development of gene-based vectors for immunization 1232
* b( }! j( [1 r! K, @3 [1 bSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
# p3 H. l  A  G64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
# T, J# {( J; |8 I7 H66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
  |) n/ `+ {- D: }6 u; L8 m! |67 Immunization in the United States 1310
68 Immunization in Europe . 1334
- ?/ K) y2 b5 T" H4 \+ Z. B* `69 Immunization in the Asia-Pacific region 1353
# Z% h. ]. V! E6 U70 Immunization in developing countries 1369
71 Community immunity 1395
- {# D8 F6 b6 X5 s72 Economic analyses of vaccine policies 1413
# f7 F; U: F/ S73 Regulation and testing of vaccines 1427
5 V" D# \$ x* K' v+ Y3 r# [74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
! M8 A5 F* c# {' k* J76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508

$ }3 [; s4 F& c8 Y# j& |( D" u
( y4 R% e& _6 y0 W5 g  L$ Z

casarett

Vaccines, 6e, 2012
) c3 ]" ~- [% _/ }  u
Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
+ v5 K. y; d5 d6 z$ W$ h  k" CLanguage: English
9 ~$ W) e. f' I& @. bISBN-10: 1455700908
( a$ l2 z4 q6 {; Z7 `7 z1 F' r7 Z2 PSize: 52.3mb (original pdf)
6 K" ^4 `6 x/ N) W! n# [
1 b) d9 I0 \4 n) \4 N& h2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
0 h( O* C) c4 j+ z$ FUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
" c& K2 e' y' B3 ]; {Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
  C/ h2 e1 R) p4 r& KClearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
% _) q; `5 t. `4 GMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
) ?, h$ y, G4 ?5 A# h7 x. _8 |Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

! [. [7 R! D; V9 L9 U# lDownload link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96